Eagle Health Investments’s Arvinas ARVN Stock Holding History

Eagle Health Investments’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-23,000	Closed	-$787K	–	28
2022 Q4	$787K	Hold	23,000	–	–	0.18%	24
2022 Q3	$1.02M	Hold	23,000	–	–	0.23%	25
2022 Q2	$968K	Hold	23,000	–	–	0.23%	25
2022 Q1	$1.55M	Hold	23,000	–	–	0.38%	25
2021 Q4	$1.89M	Hold	23,000	–	–	0.46%	25
2021 Q3	$1.89M	Hold	23,000	–	–	0.6%	24
2021 Q2	$1.77M	Buy	+23,000	New	+$1.6M	0.61%	26

Other funds holding ARVN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Eagle Health Investments's ARVN Position: Q1 2023 in Review

Eagle Health Investments sold out of Arvinas (ARVN) in Q1 2023, closing a stake of 23,000 shares — an estimated $787K sold.

Eagle Health Investments first reported a position in ARVN in Q2 2021 and held it in 7 quarters. The position peaked at $1.89M in Q3 2021. 170 funds tracked by Wall St. Rank hold ARVN as of Q1 2023.

Eagle Health Investments reported no remaining Arvinas position as of Q1 2023 after selling out during the quarter.
Eagle Health Investments sold 23,000 Arvinas shares in Q1 2023, an estimated $787K.
Eagle Health Investments first reported a position in Arvinas in Q2 2021 and held it in 7 quarters.
Eagle Health Investments's Arvinas position peaked at $1.89M in Q3 2021.
170 funds tracked by Wall St. Rank held Arvinas as of Q1 2023.

Based on Eagle Health Investments's 13F filing for Q1 2023, filed 12 May 2023.